查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1521384

全球充血性心臟衰竭治疗设备市场研究报告 - 2024 年至 2032 年产业分析、规模、份额、成长、趋势与预测

Global Congestive Heart Failure Treatment Device Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032
出版日期: | 出版商: Value Market Research | 英文 130 Pages | 商品交期: 最快1-2个工作天内

价格

全球充血性心臟衰竭治疗设备市场需求预计将从 2023 年的 282.2 亿美元达到 2032 年近 521.4 亿美元的市场规模，2024-2032 年研究期间复合年增长率为 7.06%。

充血性心臟衰竭 (CHF) 治疗设备包括专门用于管理和改善心臟衰竭症状的各种医疗设备。这些设备在为慢性心臟衰竭患者提供治疗支援方面发挥着至关重要的作用，慢性心臟衰竭患者的心臟难以有效泵血，导致肺部和身体其他部位积液。充血性心臟衰竭治疗装置的主要目标是增强心臟功能、缓解症状并提高患者的整体生活品质。

市场动态

由于全球心臟衰竭盛行率不断上升，特别是在老年族群中，心臟衰竭治疗设备市场正在显着成长。随着预期寿命的延长和生活方式的演变，心臟衰竭的发生率持续上升，需要先进的治疗方案，包括起搏器、植入式心律转復除颤器(ICD) 和心臟再同步治疗(CRT ) 设备等植入式设备。心臟护理领域的技术进步也是市场成长的关键驱动力。设备小型化、远端监控无线连接和延长电池寿命等创新正在提高充血性心臟衰竭治疗设备的功效和可用性。这些进步透过向医疗保健提供者提供即时资料来改善患者的治疗结果，并透过个人化和及时的干预措施有助于更好地管理慢性病。

此外，有利的报销政策和不断增加的医疗支出正在推动市场扩张。政府和医疗机构越来越认识到预防措施和先进治疗方案在治疗心臟衰竭等慢性疾病方面的成本效益，从而支持采用充血性心臟衰竭治疗设备。然而，与设备植入和维护相关的高昂初始成本以及对设备审批和患者安全的严格监管要求对小型充血性心臟衰竭治疗设备製造商构成了进入市场的障碍。

研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外，这些工具也对全球充血性心臟衰竭治疗设备市场的各个细分市场进行了包容性评估。充血性心臟衰竭治疗设备产业的成长和趋势为本研究提供了整体方法。

市场区隔

充血性心臟衰竭治疗设备市场报告的这一部分提供了国家和地区层面细分市场的详细资料，从而帮助策略家确定相应产品或服务的目标人群以及即将到来的机会。

按产品分类

  • 除颤器（植入式心臟復律去颤器 (ICD)（经静脉 ICD（单腔 ICD、双腔 ICD）、皮下 ICD））
  • 体外心臟去颤器（手动体外心臟去颤器、自动体外心臟去颤器（半自动体外心臟去颤器、全自动体外心臟去颤器）、穿戴式体外心臟去颤器）
  • 心律调节器（植入式心律调节器、体外心律调节器）
  • 心臟再同步治疗设备（心臟再同步治疗去颤器(CRT-D)（MRI 相容CRT-D 设备、传统CRT-D 设备）、心臟再同步治疗心律调节器(CRT-P)（MRI 相容CRT- P 设备、传统CRT -P 设备））
  • 心室辅助装置 (VAD)（左心室辅助装置 (LVAD)、右心室辅助装置 (RVAD)、双心室辅助装置 (BIVAD)、经皮心室辅助装置 (PVAD)、全人工心臟）
  • 其他产品

按最终用途

  • 医院
  • 心臟诊所
  • 门诊手术中心
  • 其他最终用户

区域分析

本节涵盖区域前景，重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲充血性心臟衰竭治疗设备市场当前和未来的需求。此外，该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。充血性心臟衰竭治疗设备市场的主要参与者包括 Abbott Laboratories、Biotronik SE & Co. Ltd.、LivaNova PLC、Medico SPA、Medtronic Plc、Mipu MedicalPort Scientific Corporation Corporation 、Oscor Inc.、Schiller AG、Shree Pacetronix Ltd.、St. Jude Medical Inc.、Stryker Corporation、Terumo Corporation。本节包含竞争格局的整体视图，包括各种策略发展，例如关键併购、未来产能、合作伙伴关係、财务概况、合作、新产品开发、新产品发布和其他发展。

如果您有任何客製化要求，请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。

目录

第一章：前言

  • 报告说明
    • 客观的
    • 目标受众
    • 独特的销售主张 (USP) 和产品
  • 研究范围
  • 研究方法论
    • 市场研究过程
    • 市场研究方法论

第 2 章：执行摘要

  • 市集亮点
  • 全球市场概况

第 3 章：充血性心臟衰竭治疗设备 - 产业分析

  • 简介 - 市场动态
  • 市场驱动因素
  • 市场限制
  • 机会
  • 产业动态
  • 波特五力分析
  • 市场吸引力分析
    • 按产品分類的市场吸引力分析
    • 按最终用途分類的市场吸引力分析
    • 市场吸引力分析：按地区

第 4 章：价值链分析

  • 价值链分析
  • 原料分析
    • 原料清单
    • 原料厂商清单
    • 主要原物料价格走势
  • 潜在买家名单
  • 行销管道
    • 直效行销
    • 间接行销
    • 行销通路发展趋势

第 5 章：全球充血性心臟衰竭治疗设备市场分析：副产品

  • 概述（按产品）
  • 按产品分类的历史和预测资料分析
  • 除颤器（植入式心臟復律去颤器 (ICD)（经静脉 ICD（单腔 ICD 双腔 ICD）、皮下 ICD））
  • 体外心臟去颤器（手动体外心臟去颤器、自动体外心臟去颤器（半自动体外心臟去颤器、全自动体外心臟去颤器）、穿戴式体外心臟去颤器）
  • 心律调节器（植入式心律调节器、体外心律调节器）
  • 心臟再同步治疗设备（心臟再同步治疗去颤器(CRT-D)（MRI 相容CRT-D 设备、传统CRT-D 设备）、心臟再同步治疗心律调节器(CRT-P)（MRI 相容CRT- P 设备、传统CRT -P 设备））
  • 心室辅助装置 (VAD)（左心室辅助装置 (LVAD)、右心室辅助装置 (RVAD)、双心室辅助装置 (BIVAD)、经皮心室辅助装置 (PVAD)、全人工心臟）
  • 其他产品

第 6 章：全球充血性心臟衰竭治疗设备市场分析：依最终用途分类

  • 按最终用途分类的概述
  • 按最终用途进行历史和预测资料分析
  • 医院
  • 心臟诊所
  • 门诊手术中心
  • 其他最终用户

第 7 章：全球充血性心臟衰竭治疗设备市场分析：按地理位置

  • 区域展望
  • 介绍
  • 北美销售分析
    • 概览、历史与预测资料销售分析
    • 北美按细分市场销售分析
    • 北美按国家销售分析
    • 美国销售分析
    • 加拿大销售分析
    • 墨西哥销售分析
  • 欧洲销售分析
    • 概览、历史与预测资料销售分析
    • 欧洲按细分市场销售分析
    • 欧洲按国家销售分析
    • 英国销售分析
    • 法国销售分析
    • 德国销售分析
    • 义大利销售分析
    • 俄罗斯销售分析
    • 欧洲其他地区销售分析
  • 亚太地区销售分析
    • 概览、历史与预测资料销售分析
    • 亚太地区按细分市场销售分析
    • 亚太地区按国家销售分析
    • 中国销售分析
    • 印度销售分析
    • 日本销售分析
    • 韩国销售分析
    • 澳洲销售分析
    • 东南亚销售分析
    • 亚太地区其他地区销售分析
  • 拉丁美洲销售分析
    • 概览、历史与预测资料销售分析
    • 拉丁美洲按细分市场销售分析
    • 拉丁美洲按国家销售分析
    • 巴西销售分析
    • 阿根廷销售分析
    • 秘鲁销售分析
    • 智利销售分析
    • 拉丁美洲其他地区销售分析
  • 中东和非洲销售分析
    • 概览、历史与预测资料销售分析
    • 中东和非洲按细分市场销售分析
    • 中东和非洲按国家销售分析
    • 沙乌地阿拉伯销售分析
    • 阿联酋销售分析
    • 以色列销售分析
    • 南非销售分析
    • 中东其他地区和非洲销售分析

第 8 章：充血性心臟衰竭治疗设备公司的竞争格局

  • 充血性心臟衰竭治疗设备市场竞争
  • 伙伴关係/协作/协议
  • 併购
  • 新产品发布
  • 其他发展

第 9 章：公司简介

  • 顶级公司市占率分析
  • 市场集中度
  • Abbott Laboratories
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Biotronik SE & Co. KG
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Boston Scientific Corporation
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Koninkilijke Philips NV
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Lepu Medical Technology Co. Ltd.
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • LivaNova PLC
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Medico SPA
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Medtronic Plc
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • MicroPort Scientific Corporation
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Oscor Inc.
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Schiller AG
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Shree Pacetronix Ltd.
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • St. Jude Medical Inc.
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Stryker Corporation
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Terumo Corporation
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展

註 - 在公司概况中，财务详细资讯和最新发展视情况而定，或对私人公司而言可能不包括在内

Product Code: VMR112115266

The global demand for Congestive Heart Failure Treatment Device Market is presumed to reach the market size of nearly USD 52.14 Billion by 2032 from USD 28.22 Billion in 2023 with a CAGR of 7.06% under the study period 2024-2032.

Congestive Heart Failure (CHF) treatment devices encompass a diverse range of medical devices specifically designed to manage and improve the symptoms of heart failure. These devices play a crucial role in providing therapeutic support to patients with CHF, a chronic condition in which the heart struggles to efficiently pump blood, leading to fluid accumulation in the lungs other areas of the body. The primary goal of congestive heart failure treatment devices is to enhance cardiac function, alleviate symptoms, and enhance patients' overall quality of life.

MARKET DYNAMICS

The CHF treatment device market is witnessing significant growth driven by the increasing prevalence of heart failure globally, particularly among elderly populations. As life expectancy rises and lifestyles evolve, the incidence of heart failure continues to escalate, necessitating advanced treatment options, including implantable devices such as pacemakers, implantable cardioverter-defibrillators (ICDs), and cardiac resynchronization therapy (CRT) devices. Technological advancements in cardiac care are also pivotal drivers of market growth. Innovations such as miniaturization of devices, wireless connectivity for remote monitoring, and improved battery life are enhancing the efficacy and usability of congestive heart failure treatment devices. These advancements improve patient outcomes by providing real-time data to healthcare providers and contribute to better management of chronic conditions through personalized and timely interventions.

Moreover, favorable reimbursement policies and increasing healthcare expenditure are bolstering market expansion. Governments and healthcare organizations increasingly recognize the cost-effectiveness of preventive measures and advanced treatment options for managing chronic diseases like heart failure, thereby supporting the adoption of congestive heart failure treatment devices. However, the high initial costs associated with device implantation and maintenance and stringent regulatory requirements for device approval and patient safety pose barriers to market entry for smaller congestive heart failure treatment device manufacturers.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Congestive Heart Failure Treatment Device. The growth and trends of Congestive Heart Failure Treatment Device industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Congestive Heart Failure Treatment Device market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

  • Defibrillators (Implantable cardioverter defibrillators (ICDs) (Transvenous ICD (Single-chamber ICDs Dual-chamber ICDs), Subcutaneous ICD))
  • External Cardioverter Defibrillator (Manual External Defibrillator, Automated External Defibrillator (Semi-Automated External Defibrillator, Fully Automated External Defibrillator), Wearable External Cardioverter Defibrillator)
  • Pacemakers (Implantable Pacemakers, External Pacemakers)
  • Cardiac Resynchronization Therapy Devices (Cardiac Resynchronization Therapy-Defibrillators (CRT-D) ( MRI Compatible CRT-D Devices, Conventional CRT-D Devices), Cardiac Resynchronization Therapy-Pacemakers (CRT-P) (MRI Compatible CRT-P Devices, Conventional CRT-P Devices))
  • Ventricular Assist Devices (VADs) (Left Ventricular Assist Devices (LVADs), Right Ventricular assist Devices (RVADs), Biventricular Assist Devices (BIVADs), Percutaneous Ventricular Assist Devices (PVADs), Total Artificial Heart)
  • Other Products

By End-Use

  • Hospitals
  • Cardiac Clinics
  • Ambulatory Surgical Centers
  • Other End-Users

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Congestive Heart Failure Treatment Device market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Congestive Heart Failure Treatment Device market include Abbott Laboratories, Biotronik SE & Co. KG, Boston Scientific Corporation, Koninkilijke Philips N.V., Lepu Medical Technology Co. Ltd., LivaNova PLC, Medico S.P.A., Medtronic Plc, MicroPort Scientific Corporation, Oscor Inc., Schiller AG, Shree Pacetronix Ltd., St. Jude Medical Inc., Stryker Corporation, Terumo Corporation. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. CONGESTIVE HEART FAILURE TREATMENT DEVICE - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Product
    • 3.7.2 Market Attractiveness Analysis By End-Use
    • 3.7.3 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET ANALYSIS BY PRODUCT

  • 5.1. Overview By Product
  • 5.2. Historical and Forecast Data Analysis By Product
  • 5.3. Defibrillators (Implantable cardioverter defibrillators (ICDs) (Transvenous ICD (Single-chamber ICDs Dual-chamber ICDs), Subcutaneous ICD)) Historic and Forecast Sales By Regions
  • 5.4. External Cardioverter Defibrillator (Manual External Defibrillator, Automated External Defibrillator (Semi-Automated External Defibrillator, Fully Automated External Defibrillator), Wearable External Cardioverter Defibrillator) Historic and Forecast Sales By Regions
  • 5.5. Pacemakers (Implantable Pacemakers, External Pacemakers) Historic and Forecast Sales By Regions
  • 5.6. Cardiac Resynchronization Therapy Devices (Cardiac Resynchronization Therapy-Defibrillators (CRT-D) ( MRI Compatible CRT-D Devices, Conventional CRT-D Devices), Cardiac Resynchronization Therapy-Pacemakers (CRT-P) (MRI Compatible CRT-P Devices, Conventional CRT-P Devices)) Historic and Forecast Sales By Regions
  • 5.7. Ventricular Assist Devices (VADs) (Left Ventricular Assist Devices (LVADs), Right Ventricular assist Devices (RVADs), Biventricular Assist Devices (BIVADs), Percutaneous Ventricular Assist Devices (PVADs), Total Artificial Heart) Historic and Forecast Sales By Regions
  • 5.8. Other Products Historic and Forecast Sales By Regions

6. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET ANALYSIS BY END-USE

  • 6.1. Overview By End-Use
  • 6.2. Historical and Forecast Data Analysis By End-Use
  • 6.3. Hospitals Historic and Forecast Sales By Regions
  • 6.4. Cardiac Clinics Historic and Forecast Sales By Regions
  • 6.5. Ambulatory Surgical Centers Historic and Forecast Sales By Regions
  • 6.6. Other End-Users Historic and Forecast Sales By Regions

7. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET ANALYSIS BY GEOGRAPHY

  • 7.1. Regional Outlook
  • 7.2. Introduction
  • 7.3. North America Sales Analysis
    • 7.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 7.3.2 North America By Segment Sales Analysis
    • 7.3.3 North America By Country Sales Analysis
    • 7.3.4 United States Sales Analysis
    • 7.3.5 Canada Sales Analysis
    • 7.3.6 Mexico Sales Analysis
  • 7.4. Europe Sales Analysis
    • 7.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 7.4.2 Europe By Segment Sales Analysis
    • 7.4.3 Europe By Country Sales Analysis
    • 7.4.4 United Kingdom Sales Analysis
    • 7.4.5 France Sales Analysis
    • 7.4.6 Germany Sales Analysis
    • 7.4.7 Italy Sales Analysis
    • 7.4.8 Russia Sales Analysis
    • 7.4.9 Rest Of Europe Sales Analysis
  • 7.5. Asia Pacific Sales Analysis
    • 7.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 7.5.2 Asia Pacific By Segment Sales Analysis
    • 7.5.3 Asia Pacific By Country Sales Analysis
    • 7.5.4 China Sales Analysis
    • 7.5.5 India Sales Analysis
    • 7.5.6 Japan Sales Analysis
    • 7.5.7 South Korea Sales Analysis
    • 7.5.8 Australia Sales Analysis
    • 7.5.9 South East Asia Sales Analysis
    • 7.5.10 Rest Of Asia Pacific Sales Analysis
  • 7.6. Latin America Sales Analysis
    • 7.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 7.6.2 Latin America By Segment Sales Analysis
    • 7.6.3 Latin America By Country Sales Analysis
    • 7.6.4 Brazil Sales Analysis
    • 7.6.5 Argentina Sales Analysis
    • 7.6.6 Peru Sales Analysis
    • 7.6.7 Chile Sales Analysis
    • 7.6.8 Rest of Latin America Sales Analysis
  • 7.7. Middle East & Africa Sales Analysis
    • 7.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 7.7.2 Middle East & Africa By Segment Sales Analysis
    • 7.7.3 Middle East & Africa By Country Sales Analysis
    • 7.7.4 Saudi Arabia Sales Analysis
    • 7.7.5 UAE Sales Analysis
    • 7.7.6 Israel Sales Analysis
    • 7.7.7 South Africa Sales Analysis
    • 7.7.8 Rest Of Middle East And Africa Sales Analysis

8. COMPETITIVE LANDSCAPE OF THE CONGESTIVE HEART FAILURE TREATMENT DEVICE COMPANIES

  • 8.1. Congestive Heart Failure Treatment Device Market Competition
  • 8.2. Partnership/Collaboration/Agreement
  • 8.3. Merger And Acquisitions
  • 8.4. New Product Launch
  • 8.5. Other Developments

9. COMPANY PROFILES OF CONGESTIVE HEART FAILURE TREATMENT DEVICE INDUSTRY

  • 9.1. Top Companies Market Share Analysis
  • 9.2. Market Concentration Rate
  • 9.3. Abbott Laboratories
    • 9.3.1 Company Overview
    • 9.3.2 Company Revenue
    • 9.3.3 Products
    • 9.3.4 Recent Developments
  • 9.4. Biotronik SE & Co. KG
    • 9.4.1 Company Overview
    • 9.4.2 Company Revenue
    • 9.4.3 Products
    • 9.4.4 Recent Developments
  • 9.5. Boston Scientific Corporation
    • 9.5.1 Company Overview
    • 9.5.2 Company Revenue
    • 9.5.3 Products
    • 9.5.4 Recent Developments
  • 9.6. Koninkilijke Philips N.V.
    • 9.6.1 Company Overview
    • 9.6.2 Company Revenue
    • 9.6.3 Products
    • 9.6.4 Recent Developments
  • 9.7. Lepu Medical Technology Co. Ltd.
    • 9.7.1 Company Overview
    • 9.7.2 Company Revenue
    • 9.7.3 Products
    • 9.7.4 Recent Developments
  • 9.8. LivaNova PLC
    • 9.8.1 Company Overview
    • 9.8.2 Company Revenue
    • 9.8.3 Products
    • 9.8.4 Recent Developments
  • 9.9. Medico S.P.A.
    • 9.9.1 Company Overview
    • 9.9.2 Company Revenue
    • 9.9.3 Products
    • 9.9.4 Recent Developments
  • 9.10. Medtronic Plc
    • 9.10.1 Company Overview
    • 9.10.2 Company Revenue
    • 9.10.3 Products
    • 9.10.4 Recent Developments
  • 9.11. MicroPort Scientific Corporation
    • 9.11.1 Company Overview
    • 9.11.2 Company Revenue
    • 9.11.3 Products
    • 9.11.4 Recent Developments
  • 9.12. Oscor Inc.
    • 9.12.1 Company Overview
    • 9.12.2 Company Revenue
    • 9.12.3 Products
    • 9.12.4 Recent Developments
  • 9.13. Schiller AG
    • 9.13.1 Company Overview
    • 9.13.2 Company Revenue
    • 9.13.3 Products
    • 9.13.4 Recent Developments
  • 9.14. Shree Pacetronix Ltd.
    • 9.14.1 Company Overview
    • 9.14.2 Company Revenue
    • 9.14.3 Products
    • 9.14.4 Recent Developments
  • 9.15. St. Jude Medical Inc.
    • 9.15.1 Company Overview
    • 9.15.2 Company Revenue
    • 9.15.3 Products
    • 9.15.4 Recent Developments
  • 9.16. Stryker Corporation
    • 9.16.1 Company Overview
    • 9.16.2 Company Revenue
    • 9.16.3 Products
    • 9.16.4 Recent Developments
  • 9.17. Terumo Corporation
    • 9.17.1 Company Overview
    • 9.17.2 Company Revenue
    • 9.17.3 Products
    • 9.17.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Product (USD MN)
  • Defibrillators (Implantable cardioverter defibrillators (ICDs) (Transvenous ICD (Single-chamber ICDs Dual-chamber ICDs), Subcutaneous ICD)) Market Sales By Geography (USD MN)
  • External Cardioverter Defibrillator (Manual External Defibrillator, Automated External Defibrillator (Semi-Automated External Defibrillator, Fully Automated External Defibrillator), Wearable External Cardioverter Defibrillator) Market Sales By Geography (USD MN)
  • Pacemakers (Implantable Pacemakers, External Pacemakers) Market Sales By Geography (USD MN)
  • Cardiac Resynchronization Therapy Devices (Cardiac Resynchronization Therapy-Defibrillators (CRT-D) ( MRI Compatible CRT-D Devices, Conventional CRT-D Devices), Cardiac Resynchronization Therapy-Pacemakers (CRT-P) (MRI Compatible CRT-P Devices, Conventional CRT-P Devices)) Market Sales By Geography (USD MN)
  • Ventricular Assist Devices (VADs) (Left Ventricular Assist Devices (LVADs), Right Ventricular assist Devices (RVADs), Biventricular Assist Devices (BIVADs), Percutaneous Ventricular Assist Devices (PVADs), Total Artificial Heart) Market Sales By Geography (USD MN)
  • Other Products Market Sales By Geography (USD MN)
  • Analysis By End-Use (USD MN)
  • Hospitals Market Sales By Geography (USD MN)
  • Cardiac Clinics Market Sales By Geography (USD MN)
  • Ambulatory Surgical Centers Market Sales By Geography (USD MN)
  • Other End-Users Market Sales By Geography (USD MN)
  • Global Congestive Heart Failure Treatment Device Market Sales By Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United States Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate By Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Congestive Heart Failure Treatment Device Report
  • Market Research Process
  • Market Research Methodology
  • Global Congestive Heart Failure Treatment Device Market Size, By Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Product
  • Market Attractiveness Analysis By End-Use
  • Market Attractiveness Analysis By Region
  • Value Chain Analysis
  • Global Market Analysis By Product (USD MN)
  • Defibrillators (Implantable cardioverter defibrillators (ICDs) (Transvenous ICD (Single-chamber ICDs Dual-chamber ICDs), Subcutaneous ICD)) Market Sales By Geography (USD MN)
  • External Cardioverter Defibrillator (Manual External Defibrillator, Automated External Defibrillator (Semi-Automated External Defibrillator, Fully Automated External Defibrillator), Wearable External Cardioverter Defibrillator) Market Sales By Geography (USD MN)
  • Pacemakers (Implantable Pacemakers, External Pacemakers) Market Sales By Geography (USD MN)
  • Cardiac Resynchronization Therapy Devices (Cardiac Resynchronization Therapy-Defibrillators (CRT-D) ( MRI Compatible CRT-D Devices, Conventional CRT-D Devices), Cardiac Resynchronization Therapy-Pacemakers (CRT-P) (MRI Compatible CRT-P Devices, Conventional CRT-P Devices)) Market Sales By Geography (USD MN)
  • Ventricular Assist Devices (VADs) (Left Ventricular Assist Devices (LVADs), Right Ventricular assist Devices (RVADs), Biventricular Assist Devices (BIVADs), Percutaneous Ventricular Assist Devices (PVADs), Total Artificial Heart) Market Sales By Geography (USD MN)
  • Other Products Market Sales By Geography (USD MN)
  • Global Market Analysis By End-Use (USD MN)
  • Hospitals Market Sales By Geography (USD MN)
  • Cardiac Clinics Market Sales By Geography (USD MN)
  • Ambulatory Surgical Centers Market Sales By Geography (USD MN)
  • Other End-Users Market Sales By Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.